Literature DB >> 14600519

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

Murielle Mary-Krause1, Laurent Cotte, Anne Simon, Maria Partisani, Dominique Costagliola.   

Abstract

BACKGROUND: In the current context of dyslipidaema, hyperglycaema and lipodystrophia observed among HIV-seropositive subjects, it is important to study the risk of myocardial infarction (MI) in this population. The French Hospital Database on HIV, which includes a large number of seropositive subjects followed for substantial periods, offers the opportunity to analyse the impact of protease inhibitors (PI) on the risk of MI among men.
METHODS: Cox model was used to study the risk factors of MI occurrence. Standardized morbidity ratios (SMR) in men exposed to PI were calculated with data from the French general male population (FGMP) of the same age as reference.
RESULTS: Between 1996 and 1999, MI was diagnosed in 60 men among 88 029 person-years (PY), including 49 cases among men exposed to PI. In the Cox model, exposure to PI was associated with a higher risk of MI [relative hazard (RH), 2.56; 95% confidence interval (CI), 1.03-6.34]. The expected incidence in the FGMP was 10.8/10,000 PY. The SMR relative to the FGMP was 0.8 (95% CI, 0.5-1.3) for men exposed to PI for < 18 months (G1), 1.5 (95% CI, 0.8-2.5) for men exposed for 18-29 months (G2) and 2.9 (95% CI, 1.5-5.0) for men exposed for >or= 30 months (G3). With G1 as reference, the SMR was 1.9 (95% CI, 1.0-3.1) for G2 and 3.6 (95% CI, 1.8-6.2) for G3.
CONCLUSION: Our results point to a duration-related effect relationship between PI and MI, with a higher MI incidence rate among men exposed to PI for 18 months or more.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600519     DOI: 10.1097/00002030-200311210-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  140 in total

1.  Ultrasonography in lesions of the carotid vessels in HIV positive patients.

Authors:  M Cristofaro; S Cicalini; E Busi Rizzi; V Schininà; N Petrosillo; C Bibbolino
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

2.  Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects.

Authors:  B M Bergersen; L Sandvik; J N Bruun; S Tonstad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-28       Impact factor: 3.267

Review 3.  Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy.

Authors:  Rajagopal V Sekhar; Farook Jahoor; Henry J Pownall; Christie M Ballantyne; Ashok Balasubramanyam
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

4.  Antiretroviral therapy and cardiovascular risk.

Authors:  E Ridha; E Devitt; M Boffito; F Boag
Journal:  BMJ Case Rep       Date:  2011-02-24

5.  Association between human immunodeficiency virus infection and stiffness of the common carotid artery.

Authors:  Eric C Seaberg; Lorie Benning; A Richey Sharrett; Jason M Lazar; Howard N Hodis; Wendy J Mack; Mark J Siedner; John P Phair; Lawrence A Kingsley; Robert C Kaplan
Journal:  Stroke       Date:  2010-08-26       Impact factor: 7.914

6.  Associations between HIV infection and subclinical coronary atherosclerosis.

Authors:  Wendy S Post; Matthew Budoff; Lawrence Kingsley; Frank J Palella; Mallory D Witt; Xiuhong Li; Richard T George; Todd T Brown; Lisa P Jacobson
Journal:  Ann Intern Med       Date:  2014-04-01       Impact factor: 25.391

7.  Endothelial function in HIV-infected persons.

Authors:  Anthony Solages; Joseph A Vita; David J Thornton; Jessica Murray; Timothy Heeren; Donald E Craven; C Robert Horsburgh
Journal:  Clin Infect Dis       Date:  2006-03-31       Impact factor: 9.079

8.  Systems Pharmacology Identifies an Arterial Wall Regulatory Gene Network Mediating Coronary Artery Disease Side Effects of Antiretroviral Therapy.

Authors:  Itziar Frades; Ben Readhead; Letizia Amadori; Simon Koplev; Husain A Talukdar; Heidi M Crane; Paul K Crane; Jason C Kovacic; Joel T Dudley; Chiara Giannarelli; Johan L M Björkegren; Inga Peter
Journal:  Circ Genom Precis Med       Date:  2019-05-06

9.  The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men.

Authors:  Matthew S Freiberg; Kathleen A McGinnis; Kevin Kraemer; Jeffrey H Samet; Joseph Conigliaro; R Curtis Ellison; Kendall Bryant; Lewis H Kuller; Amy C Justice
Journal:  J Acquir Immune Defic Syndr       Date:  2010-02       Impact factor: 3.731

10.  The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: results from a randomized trial.

Authors:  Samir K Gupta; Robert A Parker; Gregory K Robbins; Michael P Dubé
Journal:  Nephrol Dial Transplant       Date:  2005-08-16       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.